Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT06068166Completed
Open-label trial of lidocaine and ropivacaine in heart failure with reduced ejection fraction (HFrEF) (2 arms), sponsored by The First Affiliated Hospital of Harbin Medical University. Primary endpoint: Rate of heart failure mortality in the patients with HFrEF at 8.5 years. Started Jul 2013; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT06068166.